anti-SLC26A1 antibody product blogThe SLC26A1 n/a (Catalog #MBS5302993) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The SLC26A1 antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s SLC26A1 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB).
WB: 1 ug/ml. Researchers should empirically determine the suitability of the SLC26A1 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the SLC26A1 antibody with the following immunoassay(s):
Western Blot (WB) (SLC26A1 antibody (MBS5302993) used at 1 ug/ml to detect target protein.)
Rabbit polyclonal SLC26A1 antibody.
Biological Significance: SLC26A1 is a member of sulfate/anion transporter family. Family members are well conserved in their protein (aa length among species) structures, but have markedly different tissue expression patterns. Its gene is primarily expressed in the liver, pancreas, and brain. Immunogen: SLC26A1 antibody was raised using a synthetic peptide corresponding to a region with amino acids ACCSPPVRDILSRGGFLGEGPGDTAEEEQLFLSVHDAVQTARARHRELEA. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing SLC26A1 are readily searchable from our website. Different antibodies against the same target such as SLC26A1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.